Related Experiment Video
Updated: Mar 14, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles
1Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC, 27695, USA; Center for Nanotechnology in Drug Delivery and Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Abstract:
Proteins exhibiting anticancer activities, especially those capable of discriminately killing cancer cells, have attracted increasing interest in developing protein-based anticancer therapeutics. This progress report surveys recent advances in delivering anticancer proteins directly to tumor tissue for inducing apoptosis/necrosis or indirectly to antigen presenting cells for provoking immune responses. Protein delivery carriers such as inorganic particles, lipid particles, polymeric particles, DNA/protein based biomacromolecular particles as well as cell based carriers are reviewed with comments on their advantages and limitations. Future challenges and opportunities are also discussed.
Insights
Researchers are exploring protein-based therapies to target cancer cells selectively. This review covers advanced delivery methods for anticancer proteins to tumors and immune cells, discussing various carriers and future directions.
Area of Science:
- Biotechnology
- Oncology
- Drug Delivery
Background:
- Proteins with selective cancer cell-killing abilities are crucial for novel anticancer therapeutics.
- Directing these proteins to tumor sites or immune cells enhances therapeutic efficacy.
Purpose of the Study:
- To review recent advancements in the delivery of anticancer proteins.
- To discuss various protein delivery carriers and their associated benefits and drawbacks.
Main Methods:
- Survey of current literature on protein-based anticancer drug delivery.
- Analysis of different types of delivery vehicles, including inorganic, lipid, polymeric, DNA/protein, and cell-based carriers.
Main Results:
- Various carriers show promise for targeted delivery of anticancer proteins.
- Each carrier type presents unique advantages and limitations for therapeutic application.
Conclusions:
- Targeted delivery of anticancer proteins is a rapidly advancing field with significant therapeutic potential.
- Further research is needed to overcome challenges and optimize protein delivery systems for cancer treatment.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Drugs that Stabilize Microtubules

